Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy Subjects
Clinical trial NCT03036865 · COMPLETED
Trial details
- NCT number
- NCT03036865
- Sponsor
- Boston Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-04-27
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.